Related Experiment Video
Updated: Apr 26, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
MicroRNA-92 promotes gastric cancer cell proliferation and invasion through targeting FXR
1Department of Gastroenterology, Second Hospital of Shaoxing City, Shaoxing, Zhejiang Province, 312000, China, jianhuaduan@126.com.
Abstract:
MicroRNAs (miRNAs), a class of small noncoding RNAs, play critical roles in human carcinogenesis through downregulation of various target genes. In the present study, we found that miR-92 is upregulated in gastric cancer tissues compared with adjacent normal tissues. Interestingly, miR-92 expression is significantly associated with clinical characteristics of patients. Gain or loss-of-function in vitro experiments further show that miR-92 mimics significantly promoted, while its antisense oligos inhibited gastric cancer cell proliferation and invasion. Moreover, luciferase reporter assays and western blot indicated that farnesoid X receptor (FXR), is a direct target of miR-92. Therefore, our data suggest that upregulation of miR-92 may represent an important mechanism for the development of gastric cancer.
Insights
MicroRNAs (miRNAs) like miR-92 are upregulated in gastric cancer, promoting tumor growth and invasion. Targeting miR-92 could be a new strategy for treating this disease.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MicroRNAs (miRNAs) are small noncoding RNAs crucial in regulating gene expression.
- Dysregulation of miRNAs is implicated in various human cancers, including gastric cancer.
- Understanding specific miRNA roles, like miR-92, is vital for cancer research.
Purpose of the Study:
- To investigate the role of miR-92 in gastric cancer development.
- To determine the association between miR-92 expression and clinical characteristics.
- To identify direct targets of miR-92 in gastric cancer cells.
Main Methods:
- Quantitative analysis of miR-92 expression in gastric cancer tissues versus normal tissues.
- In vitro gain-of-function and loss-of-function experiments to assess miR-92's impact on cell proliferation and invasion.
- Luciferase reporter assays and Western blot to validate direct targeting of Farnesoid X Receptor (FXR) by miR-92.
Main Results:
- miR-92 was significantly upregulated in gastric cancer tissues.
- miR-92 expression levels correlated with specific clinical characteristics of patients.
- Overexpression of miR-92 enhanced gastric cancer cell proliferation and invasion.
- Inhibition of miR-92 suppressed these cellular behaviors.
- FXR was identified as a direct target gene of miR-92.
Conclusions:
- Upregulation of miR-92 is a potential mechanism driving gastric cancer progression.
- miR-92 promotes gastric cancer cell proliferation and invasion, partly through targeting FXR.
- miR-92 may serve as a diagnostic biomarker or therapeutic target for gastric cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

